Catatonia under medication with risperidone in a 61-year-old patient.
This report describes the case of a 61-year-old female schizophrenic patient with status post-frontal lobotomy some 35 years ago with prominent paranoid delusions. This woman developed severe catatonia under medication with a serotonergic/dopaminergic neuroleptic, risperidone, at a dose of up to 5 mg daily. The catatonic disorder was dose-dependent and subsided immediately after switching the medication to another atypical antipsychotic, clozapine. Given the negative history for catatonia in this patient, the temporal coincidence of administration of risperidone and catatonia is a novel finding.
Bahro
M
M
University of Berne Psychiatric Department (East), Switzerland.
Kämpf
C
C
Strnad
J
J
D014150:Antipsychotic Agents / Q000009:adverse effects*; D002389:Catatonia / Q000139:chemically induced*; D003024:Clozapine / Q000627:therapeutic use; D003702:Delusions / Q000188:drug therapy* / Q000209:etiology*; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D008875:Middle Aged; D018967:Risperidone / Q000009:adverse effects*; D012563:Schizophrenia, Paranoid / Q000523:psychology*; D016312:Treatment Refusal
D014150:Antipsychotic Agents; D003024:Clozapine; D018967:Risperidone